Published in Midwifery on February 20, 2008
Confidence of primary care physicians in their ability to carry out basic medical genetic tasks-a European survey in five countries-Part 1. J Community Genet (2010) 1.47
Genetic educational needs and the role of genetics in primary care: a focus group study with multiple perspectives. BMC Fam Pract (2011) 1.37
Prioritization of future genetics education for general practitioners: a Delphi study. Genet Med (2012) 1.10
Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: general practitioners' and breast surgeons' current practice and preferred practice responsibilities. J Community Genet (2013) 0.81
The application of genetics and nutritional genomics in practice: an international survey of knowledge, involvement and confidence among dietitians in the US, Australia and the UK. Genes Nutr (2013) 0.79
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85
Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial. BMJ (2010) 3.56
Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care (2005) 1.65
EuroGentest: DNA-based testing for heritable disorders in Europe. Community Genet (2008) 1.63
Regulations and practices of genetic counselling in 38 European countries: the perspective of national representatives. Eur J Hum Genet (2008) 1.63
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders. Eur J Hum Genet (2011) 1.57
WRN mutations in Werner syndrome patients: genomic rearrangements, unusual intronic mutations and ethnic-specific alterations. Hum Genet (2010) 1.50
Confidence of primary care physicians in their ability to carry out basic medical genetic tasks-a European survey in five countries-Part 1. J Community Genet (2010) 1.47
Provision of genetic services in Europe: current practices and issues. Eur J Hum Genet (2003) 1.43
Community genetics. Its definition 2010. J Community Genet (2010) 1.42
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2010) 1.41
Preconceptional genetic carrier testing and the commercial offer directly-to-consumers. Hum Reprod (2011) 1.32
Virtual Screening with AutoDock: Theory and Practice. Expert Opin Drug Discov (2010) 1.30
Testing for BRCA1 mutations: a cost-effectiveness analysis. Eur J Hum Genet (2002) 1.26
Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genet (2011) 1.23
The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer. Gynecol Oncol (2005) 1.23
The wide variation of definitions of genetic testing in international recommendations, guidelines and reports. J Community Genet (2012) 1.19
Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view. Psychooncology (2010) 1.18
Genetics in clinical practice: general practitioners' educational priorities in European countries. Genet Med (2008) 1.18
Informed decision making in the context of prenatal screening. Patient Educ Couns (2005) 1.17
Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genet Med (2008) 1.16
Assessing educational priorities in genetics for general practitioners and specialists in five countries: factor structure of the Genetic-Educational Priorities (Gen-EP) scale. Genet Med (2008) 1.14
Scope of definitions of genetic testing: evidence from a EuroGentest survey. J Community Genet (2010) 1.11
Definitions of genetic testing in European legal documents. J Community Genet (2012) 1.10
The parent-of-origin effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentas. Mol Hum Reprod (2004) 1.09
Patients' characteristics and rate of Internet use to obtain cancer information. J Public Health (Oxf) (2006) 1.08
Benchmarks for cystic fibrosis carrier screening: a European consensus document. J Cyst Fibros (2010) 1.08
Mary Seacole: global nurse extraordinaire. J Adv Nurs (2014) 1.06
An excess of chromosome 1 breakpoints in male infertility. Eur J Hum Genet (2004) 1.06
Diffusion of information about genetic risk within families. Neuromuscul Disord (1996) 1.05
Report of an international survey of molecular genetic testing laboratories. Community Genet (2007) 1.04
Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics. Hum Mutat (2013) 1.04
The feasibility of using ethnicity as a primary tool for antenatal selective screening for sickle cell disorders: pointers from the research evidence. Soc Sci Med (2003) 1.03
DNA-based genetic testing is rising steeply in a national health care system with open access to services: a survey of genetic test use in Germany, 1996-2002. Genet Test (2005) 1.03
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2010) 1.01
Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes. Fam Cancer (2008) 1.00
Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers. BMC Public Health (2009) 1.00
Cross-cultural validation of the Decisional Conflict Scale in a sample of French patients. Qual Life Res (2006) 1.00
What is ideal genetic counselling? A survey of current international guidelines. Eur J Hum Genet (2008) 0.99
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat (2012) 0.98
Allosteric regulation of substrate channeling in tryptophan synthase: modulation of the L-serine reaction in stage I of the beta-reaction by alpha-site ligands. Biochemistry (2007) 0.98
Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testing. Int J Technol Assess Health Care (2003) 0.98
Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing. Eur J Cancer (2006) 0.97
Synthesis and characterization of allosteric probes of substrate channeling in the tryptophan synthase bienzyme complex. Biochemistry (2007) 0.96
Consent for biobanking: assessing the understanding and views of cancer patients. J Natl Cancer Inst (2010) 0.95
Community genetics in the era of public health genomics. Community Genet (2008) 0.95
Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genet (2003) 0.95
Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol (2002) 0.94
Genetically modified donor leukocyte transfusion and graft-versus-leukemia effect after allogeneic stem cell transplantation. Hum Gene Ther (2011) 0.93
Cytogenetic Guidelines and Quality Assurance: a common European framework for quality assessment for constitutional and acquired cytogenetic investigations. Eur J Hum Genet (2007) 0.92
Linkage and association studies of IL1B and IL1RN gene polymorphisms in preeclampsia. Hypertens Pregnancy (2002) 0.91
Testing participation in BRCA1/2-positive families: initiator role of index cases. Genet Test (2003) 0.90
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Genetic education for non-geneticist health professionals. Community Genet (2006) 0.89
Attitudes of potential providers towards preconceptional cystic fibrosis carrier screening. J Genet Couns (2004) 0.88
Genetic education and nongenetic health professionals: educational providers and curricula in Europe. Genet Med (2005) 0.88
Education in medical genetics for physicians: Germany. Community Genet (2006) 0.87
Preconceptional cystic fibrosis carrier screening: attitudes and intentions of the target population. Genet Test (2004) 0.87
Prevalence of stroke and vascular risk factors among first-degree relatives of stroke patients and control subjects. A prospective consecutive study. Cerebrovasc Dis (2005) 0.87
Does prenatal screening influence anxiety levels of pregnant women? A longitudinal randomised controlled trial. Prenat Diagn (2006) 0.87
Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine. Vaccine (2003) 0.86
Major incident planning in primary care trusts in north-west England: a cross-sectional survey. Health Serv Manage Res (2010) 0.86
Ischaemic stroke in hypertensive patients is associated with variations in the PDE4D genome region. Eur J Hum Genet (2008) 0.86
Association of HTRA1 and ARMS2 gene variation with drusen formation in rhesus macaques. Exp Eye Res (2008) 0.86
How should preconceptional cystic fibrosis carrier screening be provided? Opinions of potential providers and the target population. Community Genet (2003) 0.85
Behavioral and economic impact of a familial history of cancers. Fam Cancer (2005) 0.85
A large-sample assessment of possible association between ischaemic stroke and rs12188950 in the PDE4D gene. Eur J Hum Genet (2012) 0.85
Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis? Ann Rheum Dis (2007) 0.85
Testing the children: do non-genetic health-care providers differ in their decision to advise genetic presymptomatic testing on minors? A cross-sectional study in five countries in the European Union. Genet Test Mol Biomarkers (2009) 0.85
Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status. Breast Cancer Res Treat (2014) 0.84
Preparedness of emergency departments in northwest England for managing chemical incidents: a structured interview survey. BMC Emerg Med (2007) 0.84